Tag Archives: double

U.S. employers covering weight-loss drugs could nearly double in 2024 – survey

The number of U.S. employers who cover obesity medications, including Wegovy from Novo Nordisk (NOVOb.CO) that belongs to a class of GLP-1 drugs, could nearly double next year, according to a survey. The survey of 502 employers by Accolade (ACCD.O), a company that provides healthcare programs for employers, and research firm Savanta said …

Read More »
[tta_listen_btn]